B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma
Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma
Gomekli Shows Early Activity in Pediatric Low Grade Glioma
Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma